Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internatio...
Q1 2026
Apr 8, 2026
FY 2025
Mar 30, 2026
Q4 2025
Q2 2025
Sep 29, 2025
Q1 2025
Apr 15, 2025